Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum matrix metalloproteinase-3 in systemic sclerosis.

Masatoshi Jinnin1, Hironobu Ihn, Yoshihide Asano

  • 1Department of Dermatology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, 113-8655 Tokyo, Japan.

Archives of Dermatological Research
|April 20, 2004
PubMed
Summary

Increased serum matrix metalloproteinase-3 (MMP-3) may indicate rheumatoid arthritis (RA) development in women with systemic sclerosis (SSc). Careful monitoring of SSc patients with elevated MMP-3 is recommended due to potential overlapping RA.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region.

Nature communications·2026
Same author

Whole-genome sequencing reveals rare and structural variants contributing to psoriasis and identifies CERCAM as a risk gene.

Cell genomics·2025
Same author

The Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Repeated Heart Failure Rehospitalizations Among Elderly Patients With Acute Decompensated Heart Failure: The ROSES-HF Study.

The American journal of cardiology·2025
Same author

Wound, pressure ulcer, and burn guidelines - 3: Guidelines for the diagnosis and treatment of diabetic ulcers and gangrene, second edition.

The Journal of dermatology·2025
Same author

Blood DNA virome associates with autoimmune diseases and COVID-19.

Nature genetics·2025
Same author

Wound, Pressure Ulcer, and Burn Guidelines-5: Guidelines for the management of lower leg ulcers and varicose veins, second edition.

The Journal of dermatology·2024

Area of Science:

  • Rheumatology
  • Immunology
  • Biochemistry

Background:

  • Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis.
  • Comorbidities like rheumatoid arthritis (RA) can complicate SSc management.
  • Matrix metalloproteinase-3 (MMP-3) is an enzyme involved in tissue remodeling and inflammation.

Purpose of the Study:

  • To measure serum MMP-3 levels in patients with SSc.
  • To explore the clinical significance of MMP-3 in SSc, particularly its association with RA development.

Main Methods:

  • Serum samples were collected from 83 SSc patients and 30 healthy controls.
  • Enzyme-linked immunosorbent assay (ELISA) was used to quantify serum MMP-3 levels.
  • Clinical data, including development of RA, arthralgia, C-reactive protein (CRP), and rheumatoid factor (RF), were analyzed.

Related Experiment Videos

Main Results:

  • No significant difference in serum MMP-3 was found between SSc patients and healthy controls.
  • In female SSc patients, elevated MMP-3 levels were associated with a higher likelihood of developing RA.
  • Increased MMP-3 levels correlated with arthralgia, elevated CRP, and elevated RF in SSc patients.

Conclusions:

  • Elevated serum MMP-3 may serve as a predictive biomarker for RA development in SSc patients.
  • Female SSc patients with increased MMP-3 require vigilant follow-up for potential overlapping RA.
  • MMP-3 warrants further investigation as a potential therapeutic target in SSc-RA overlap syndromes.